Perrigo Company PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Perrigo Company PLC with three other
companies in this sector in UNITED STATES :
Alexion Pharmaceuticals, Inc.
sales of $4.95 billion
of which 80%
Vertex Pharmaceuticals Inc
of which 100%
was Pharmaceuticals), and
Eisai Company Limited
of which 88%
was Pharmaceutical Business).
During the year ended December of 2019, sales at
Perrigo Company PLC were $4.84 billion.
increase of 2.2%
versus 2018, when the company's sales were $4.73 billion.
Despite this increase, sales are still
below the level achieved in 2017, when Perrigo Company PLC
reported sales of $4.95 billion.
Sales of Csca saw an increase
3.2% in 2019, from
$2.41 billion to $2.49 billion.
Not all segments of Perrigo Company PLC experienced an increase in sales in 2019:
sales of Csci fell 7.6% to $1.38 billion.